Wild-Type Parainfluenza Virus Type 2

Human parainfluenza virus type 2 (HPIV-2) is a significant respiratory pathogen, primarily infecting infants, young children, and immunocompromised individuals. It belongs to the genus Respirovirus in the family Paramyxoviridae. The virus is transmitted through direct contact with infected respiratory secretions or aerosols. The virus enters the host through the nasopharynx and attacks epithelial cells lining the upper and lower respiratory tracts. Viral replication induces cell lysis, leading to local inflammation and symptoms such as croup (laryngotracheobronchitis), bronchiolitis, and pneumonia. HPIV-2 utilizes the hemagglutinin-neuraminidase (HN) and fusion (F) glycoproteins to bind to sialic acid receptors on host cells, promoting membrane fusion and viral entry. While an immune response is crucial for viral clearance, it may exacerbate tissue damage and worsen the disease. Due to incomplete immunity, reinfection is common, but subsequent infections are generally mild.

HPIV-2 is an enveloped, pleomorphic virus approximately 150-300 nanometers in diameter. Its lipid bilayer envelope is studded with two key glycoproteins: the HN protein, which mediates receptor binding and neuraminidase activity, and the F protein, which drives membrane fusion. Beneath the envelope lies a matrix (M) protein layer, providing structural integrity. The viral core consists of a single-stranded, negative-sense RNA genome (approximately 15,000 nucleotides) tightly associated with the nucleocapsid (N) protein, forming a helical ribonucleoprotein complex. The genome encodes six major proteins: N, phosphoprotein (P), matrix (M), fusion (F), hemagglutinin-neuraminidase (HN), and large polymerase (L), arranged in the order 3′-N-P-M-F-HN-L-5′. The P gene also produces accessory proteins (V and D) through RNA editing, thereby modulating the host immune response. HPIV-2 replicates in the cytoplasm, utilizing its RNA-dependent RNA polymerase (L protein) to transcribe mRNA and replicate the genome.